Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Results Update

Rossari Biotech Results Update

Rossari Biotech announced its FY26 results, reporting 15% revenue growth to ₹2,396.40 Crore. Q4 FY26 revenue reached a record ₹684.9 Crore, up 18% YoY, while annual PAT rose 9% to ₹149.2 Crore. The company also commissioned 15,000 MTPA additional capacity at its Dahej facility and recommended a ₹0.50 per share dividend.

Key figures
Value₹2,396 Cr
Source

BSE filing, NSE: ROSSARI. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Rossari Biotech Ltd: key numbers

Share price
₹408.40
Market cap
₹2,262 Cr
Revenue (annual)
₹2,396 Cr
Net profit (annual)
₹149.2 Cr
P/E (TTM)
14.8×Sector 34.1×
Promoter holding
68.14%+0.00% QoQ
FII holding
1.84%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Rossari Biotech Ltd

All →

Other results update announcements

All →